熱門資訊> 正文
AVTX、WISA和HTLD均为上市前涨幅股
2024-04-16 20:45
- Gainers WiSA Technologies (WISA) +64%.
- Peraso (PRSO) +51% Introduces New mmWave Wi-Fi Solution Utilizing Peraso's X710 Chipset Technology.
- Macatawa Bank (MCBC) +39%.
- BioRestorative Therapies (BRTX) +25% Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment.
- Cullinan Oncology (CGEM) +20% expands into autoimmune diseases.
- Intra-Cellular Therapies (ITCI) +20% Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder.
- ParaZero Technologies (PRZO) +11%.
- Enovix Corporation (ENVX) +9% completes Factory Acceptance Testing for its Gen2 Agility Line.
- Mobile-health Network Solutions (MNDR) +8%.
- Avalo Therapeutics (AVTX) +8%.
- Unitedhealth Group (UNH) +8%.
- Telefonaktiebolaget L M Ericsson (ERIC) +8%.
- Heartland Express (HTLD) +7%.
- HNR Acquisition (HNRA) +11%.
- Agilon Health (AGL) +7%.
- Connexa Sports Technologies (YYAI) +5%.
- Mobilicom Limited (MOB) +6%.
- Oncocyte Corporation (OCX) +5%.
More on premarkets gainers and stock
- WiSA Technologies to effect 1-for-150 reverse stock split
- WiSA Technologies drops 5%, accepts Nasdaq compliance plan
- Seeking Alpha’s Quant Rating on Avalo Therapeutics
- Historical earnings data for Avalo Therapeutics
- Financial information for Avalo Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
